Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$1.99
-$0.06-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.00M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.00M | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 70.00M | -- | -- | -- | -- |
| SG&A Expenses | 22.79M | 24.52M | 27.06M | 29.70M | 27.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.06M | 75.84M | 81.36M | 87.24M | 85.15M |
| Operating Income | -1.06M | -75.84M | -81.36M | -87.24M | -85.15M |
| Income Before Tax | 5.09M | -69.68M | -73.10M | -80.55M | -79.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.09 | -69.68 | -73.10 | -80.55 | -79.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.09M | -69.68M | -73.10M | -80.55M | -79.79M |
| EBIT | -1.06M | -75.84M | -81.36M | -87.24M | -85.15M |
| EBITDA | -716.00K | -75.49M | -81.02M | -86.87M | -84.74M |
| EPS Basic | 0.08 | -1.27 | -1.36 | -1.54 | -1.70 |
| Normalized Basic EPS | 0.07 | -0.78 | -0.87 | -0.98 | -1.09 |
| EPS Diluted | 0.06 | -1.27 | -1.36 | -1.54 | -1.70 |
| Normalized Diluted EPS | 0.06 | -0.78 | -0.87 | -0.98 | -1.09 |
| Average Basic Shares Outstanding | 224.93M | 220.08M | 215.11M | 209.54M | 190.91M |
| Average Diluted Shares Outstanding | 225.94M | 220.08M | 215.11M | 209.54M | 190.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |